{"name":"Advanced Ophthalmic Pharma","slug":"advanced-ophthalmic-pharma","ticker":"","exchange":"","domain":"","description":"Advanced Ophthalmic Pharma is a specialty pharmaceutical company focused on developing innovative treatments for ophthalmic conditions. The company's lead product, Vigamox administered in spray form, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Vigamox - administration in spray form","genericName":"Vigamox - administration in spray form","slug":"vigamox-administration-in-spray-form","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Vigamox - administration in spray form","genericName":"Vigamox - administration in spray form","slug":"vigamox-administration-in-spray-form","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-04-06","type":"pipeline","source":"Devdiscourse","summary":"Rajnath Singh Launches Advanced Military Medical Centres, Pushes for Research-Led Healthcare and Pharma Innovation - Devdiscourse","headline":"Rajnath Singh Launches Advanced Military Medical Centres, Pushes for Research-Led Healthcare and Pharma Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQRDZfb2tqSGx4cExYd2V6cjB2YXlXVnVON0xzRHRleVdxUWprcS1QY0hZeHJNZFROM2R5Y1lyeEd0T1hnMjRBalNTUmNxMmpxU1hmTDhKemxSTGJ4ZE55akprekhUU0wwTmVyOUhwUElEMUNSMUd1RktWSjMybnNaVUk3aEdkNHUxUkR5TEY4cXZlRWVaeWNIRXlRaEZsVGpZWUtJMmtCRnR4WENnaFlpVVI0Ti00WXRTN1g1d0dtdENMVlVmbGFPRnBB?oc=5","date":"2026-04-05","type":"regulatory","source":"IndexBox","summary":"Ophthalmic Drug Packaging Market to 2035 Driven by Demand for Advanced Sterile Systems for Biologics - IndexBox","headline":"Ophthalmic Drug Packaging Market to 2035 Driven by Demand for Advanced Sterile Systems for Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxONHR0R3p3V01rUk5NdVZ5dXZELWZtUjRUc05lRTRLTXJUYVppYkFYOTZma29fZXZ6VHhZMHFTNnZ1ZUNfSDVScHNWdG81YWVESmE2VkdHTFlmVkZkVUhtVjN3WFVjQkVia09fc1Jicmc4MzdROC1LSG1HT2pWM0NRTi1LLXdrb29DMlRldkxyWUUxVlZDZHVucF9DZ2hWMmRpdzh5Mm9OSFc5cWJiYVhEelBvb0hQNy1kY2tSdnVFbw?oc=5","date":"2026-02-17","type":"regulatory","source":"Eyes On Eyecare","summary":"FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials - Eyes On Eyecare","headline":"FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOUzRaR2NOR0NRd0JkLWN3aDBwWXBKU3AzRGlvVEFTS1pwM2U4c3ZQUVFDRlB4M21kZEhHNkRRalFYZjhHbFl2b090MEZycGI0My11bDIyLTBERDRyNVRHNF94bkJqeVZKalNIRXVhSWFWVFMzcmVpRzBkY0NpcWZkSjNFWkNEb29pdHc2RlpyNnVDX1dsRUI0OVJBOEZjeXhWV0p5UzE5M3gzM3liNmh4Rm16MUJwZTQ0VXV2d1ZOam5rU2NQcHNuTl9ZZ0tacF9TVmlnYg?oc=5","date":"2026-02-15","type":"regulatory","source":"TipRanks","summary":"Cloudbreak Pharma Wins FDA Green Light to Advance Presbyopia Drug CBT-199 Into Phase 2 - TipRanks","headline":"Cloudbreak Pharma Wins FDA Green Light to Advance Presbyopia Drug CBT-199 Into Phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxNTkdScVptYklQRW1ZTXdrb29sRFVZS3l1N2xRWlFmR3JXWXM5Y2xnd3NjdFVJTlc4emVxcXlBYTIwRnFPVHJJbWI0X3VHQ1FFVGVXQkJIU3dDVTM5Uy1RVHljZDd2T0MxSnZBZDItWVhnQS1IeDAxUGF5Q09uNmhJOHRpR3pEcVA5U1dxVEhOYmdEczJmbVk5andHZ2tfOGh6cjMyYlB1cklnaEc2UTVmRWJuZGpObG84dHZsbDZzSTJsa21EM24zSWhyRThFeUd4TVZCMHluLVhVNmZrSE9VczNMNXd5X0d3V3BUQzBORzI?oc=5","date":"2026-02-10","type":"pipeline","source":"BioSpace","summary":"OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer - BioSpace","headline":"OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVW51VjBDUl9KQjZFNjAwMlVVeXRGdHV6dDhsalY2V0JNcXRTSUZRSnByVUZmbWg4R3FjU1lmWkZuN29kanBIZ180dEk2VFRTUWdMaEIwZGp6SzNvRUxtbWQwZC1OR01Kdjk4X0RJR1U4UWtUR0NaMmc4VFRvVEMwWW5reDRhVi1HdFI1NUV2OXdwbkRYNU50QnJGTmJGZWpWY3dhXzhQeG5aM1VpWTdmQzIxenpZX3ZxWHF6d2xnWHVqbi1BSlhIMVpueHh2eWpkc19FTUZodXg5dw?oc=5","date":"2026-01-12","type":"pipeline","source":"Aptar","summary":"Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™ - Aptar","headline":"Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQU2pJb3dyaklsUjdfcUdUUHNBcWVUQmtOdmpYdTVwVjk3U0habUdtTl9GV2ttWTI2OWVQTGRNaFZncC1xcHFJSVp6bUhELTZjZ190OUxmRkRMMmtTRTVxbV9IWFhfX192ZXFrSl8xWUd2MFVJRXlmSkJRbUxYd1R0Q3FiRV9GdHB0OVFIS3FKS2FKeFdYaVlGN0RFcjdXYk41SlF1OVZVT0YzSmZaT19QNW1zT3NvTzdDMGFSSVBacG00a2Vrejc3dVFxVzRpSjJheTR2cVJTMzU?oc=5","date":"2025-12-06","type":"pipeline","source":"BioSpectrum Asia","summary":"Santen and SERI to advance disease-modifying therapies for major eye diseases in Singapore - BioSpectrum Asia","headline":"Santen and SERI to advance disease-modifying therapies for major eye diseases in Singapore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPeFYxNmktQ2lVMVVqUFpFeWVkdGRldjBmVlEzZDNlWHJ3MEVXTkttOV84NVBYVWl3TVZmNER5M1dxRkVUV0o2c3NTdVNlM0VXZzJ5WXN4X1NFeTcycnFMNjl2TnFCQ2tJb2VXaGFjMUJQOGd6clY1YVdJZWZlV3NCZEotdWZOeWFJRWlCSXJUTmU3TFFNR191bUxJZFh1Y2ZpUUZUOVNGemJvU0FmQ3d6NA?oc=5","date":"2025-11-25","type":"regulatory","source":"Eyes On Eyecare","summary":"Ocuvex resubmits FDA CRL for brimonidine tartrate 0.35% NDA - Eyes On Eyecare","headline":"Ocuvex resubmits FDA CRL for brimonidine tartrate 0.35% NDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQczh1WnlPYjBjdXdzb25SMnRoT1Y5LXNGVGhDbURnMVAxZFNfNXVlMGVTRTBJOWRQNnhFX0pBUE1BVXh6YzBoT3RFTGlIbmVPTW4zMWJwYTlrQ1pfWlBOd3J4cEJnNDNFemhJalBOUktkY1JaVFVFbzk0bXJlVm9meUFIa2xJN3VDTmNWeG5FQzB0b192bjBkY194Z1VBQnhSM2Q0d2pkOHJYSl85dk1Qb1Bja1FxMEl4c3ktdzkyYy02dw?oc=5","date":"2025-08-04","type":"deal","source":"Optometry Times","summary":"Viridian partners with Kissei Pharmaceutical to advance thyroid eye disease therapies in Japan - Optometry Times","headline":"Viridian partners with Kissei Pharmaceutical to advance thyroid eye disease therapies in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNT1NYbGFYdFYtQ0MwLV9tQ3FQODZHUHdWa2JKRy1FMVdfazdCQVR3VzdyWVlINEpGc2xCU0k0VVZGaXlsSnV6dFlTOHh6dnhRUlhfcXYyMEFWNXV5MUU1Uno0R0dsUV93Z0NmT2JSeU5pSl9pTk43cW1aTXNrR1lQQ3JQdmZOSUZDM1pXa3ljNWgxRWdy?oc=5","date":"2025-06-18","type":"pipeline","source":"MarketsandMarkets","summary":"Ophthalmology Drugs Market Report 2025-2030, By Molecule, Modality, and Geo - MarketsandMarkets","headline":"Ophthalmology Drugs Market Report 2025-2030, By Molecule, Modality, and Geo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxOVkFpeTZQX2IyVnNZUmIzRVNya29EZk5jMHdJNkxzV1pQdTZ3dkhER2pKSTR0SXhPUF9SQUJPZHV6elJhS3hEOXhUeG0ySWF6X25qdWZDS1dCdjBhbE9faWl1NXJQZGZEUzk1Z21tendyN011ZXlkM3dlSnFId1Nmb2NyaTVueUREeUw5eVo0NVZ5X1NxWUYxZ2Y5NWdHVkFET0tQV01yaDFwU3VVQ1BDWk96RldkZm8wblBoZnp2OGFCdFhESlZrSmpxbzJQUnZBc3pranJvVzh4dzd2azJ3TkZfd2RLWExBbU1fenJHTHVNcWtvS0w1aEt4ZVVpMDl0ZXhrSUlYWFFSX0NJeWJZOVBJM0JYUlRLUWFDbQ?oc=5","date":"2025-06-02","type":"pipeline","source":"GlobeNewswire","summary":"SpyGlass Pharma Raises $75 Million Series D Funding to - GlobeNewswire","headline":"SpyGlass Pharma Raises $75 Million Series D Funding to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPOGNDaDJ0S3NuWGhKbE9ZTVJ6Mml0bmQtMzlMYUZvcTRvUnFFWE5ENzhZVFUzR1VUbTJzbUc1Q3RXWkZKVnpTMkVoOGIxVG5rV3RnMmxkc0Vrb3h0Z0tObGdIZEdDMEZyemloVEw1RVJDaW4zejJtSUc0SDhtd0s5dmhwSVBDVENSMDAza1RpcG5MaGVzTjY5ZWN4Z0xGeElHaURsUzJ6bDNhM010MkpEZVZJXzVwVTFEaC1DVmo5V005b3pfaF9CUFkzSElYNVR3bXlqekx6c2o?oc=5","date":"2025-02-18","type":"pipeline","source":"PR Newswire","summary":"Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection - PR Newswire","headline":"Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}